Status:

COMPLETED

Implementing Hypertension Screening Guidelines in Primary Care

Lead Sponsor:

Columbia University

Collaborating Sponsors:

Agency for Healthcare Research and Quality (AHRQ)

Weill Medical College of Cornell University

Conditions:

Hypertension,Essential

White Coat Hypertension

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The goal of this study is to use a cluster-randomized design (1:1 ratio) among 8 primary care clinics affiliated with New York-Presbyterian Hospital to test the effectiveness of a theory-informed mult...

Detailed Description

The goal of this study is to assess the effect of a multifaceted implementation strategy aimed at increasing adherence to the 2015 U.S. Preventive Services Task Force (USPSTF) recommendations for hype...

Eligibility Criteria

Inclusion

  • Patient Inclusion Criteria (as per electronic medical records):
  • Elevated blood pressure (BP) (systolic BP\>=140 mmHg or diastolic BP \>=90 mmHg) at a scheduled clinic visit with a primary care provider from a clinic that is participating in the study; if multiple BP readings were taken from a visit, then the average of the readings will be used
  • Patient Exclusion Criteria (as per electronic medical records):
  • Prior diagnosis of hypertension
  • Prior diagnosis of white-coat hypertension
  • Prior evaluation for white-coat hypertension by 24-hr ABPM or HBPM
  • Prescribed antihypertensive medication
  • Manual office BP \<140/90 mmHg
  • Severely elevated BP (systolic BP\>=180 mmHg or diastolic BP\>=110 mmHg)
  • Evidence of target-organ damage (chronic kidney disease, cardiovascular disease)
  • Clinic
  • Primary care clinics that are part of the New York-Presbyterian Hospital Ambulatory Care Network and were not part of implementation development
  • Clinic

Exclusion

  • Medical director of clinic declines to participate in cluster randomized trial

Key Trial Info

Start Date :

April 1 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2022

Estimated Enrollment :

1186 Patients enrolled

Trial Details

Trial ID

NCT03480217

Start Date

April 1 2018

End Date

October 1 2022

Last Update

June 13 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Center for Behavioral Cardiovascular Health

New York, New York, United States, 10032

2

Weill Cornell Medical Center

New York, New York, United States, 10065